Current research findings indicate that circRNAs can modulate the sensitivity of chemotherapy drugs in some tumors, such as in osteosarcoma, where they can promote progression and regulate cisplatin sensitivity through the miR-339-3p/IGF1R axis (Li et al., 2021). This evidence concerns the gene IGF1R and osteosarcoma.